Bristol-Myers Squibb | BMY - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q3 Sep/2025 1.60 1.63 Oct/29
FY2026Q2 Jun/2026 2.04 1.61 1.46 Jul/30
FY2026Q1 Mar/2026 1.58 1.45 1.80 Apr/30
FY2025Q4 Dec/2025 1.26 1.61 1.67 Feb/05
FY2025Q3 Sep/2025 1.63 1.69 1.80 Oct/30




Eps تغيير تاريخ
AbbVie USD 3.65 1 2026-06
Abbott USD 1.31 0.16 2026-06
ALKERMES USD 0 0.4 2026-06
Amgen USD 6.29 1.14 2026-06
AstraZeneca USD 2.63 0.05 2026-06
Biogen USD 3.6 0.03 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Coherus Biosciences USD -0.43 0.06 2025-12
Drreddys Laboratories INR 0.06 0.1 2026-03
Eli Lilly USD 8.38 0.17 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
J&J USD 2.9 0.2 2026-06
Medtronic USD 1.55 0.19 2026-03
Merck USD -0.13 1.15 2026-06
Novartis USD 2.41 0.42 2026-06
Novo Nordisk DKK 4.74 6.17 2026-06
Perrigo USD 0.5 0.07 2026-06
Pfizer USD 0.77 0.02 2026-06
Phibro Animal Health USD 0.78 0.1 2025-12
Prestige Brands USD 0.98 0.25 2026-06
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sanofi EUR 2.09 0.21 2026-06
Sanofi EUR 2.17 2.84 2026-03
United Therapeutics USD 7.27 1.45 2026-06
Zoetis USD 1.87 0.34 2026-06